InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Kelly, Scott. Director active across 2 companies, notably Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.). In total, 5 disclosures have been published. Activity tracked since 29 May 2026. The latest transaction was filed on 10 July 2026 (50 - Grant of options). Regulator: SEDI. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations